| Preoperative Portal Vein Thrombosis | Postoperative Vascular Thrombosis | ||||
---|---|---|---|---|---|---|
Demographic Characteristics | Yes (N = 4,247) | No (N = 61,399) | P-value | Yes (N = 1,233) | No (N = 6,824) | P-value |
Age (year) | 54.1 | 52.4 | <0.0001* | 49.8 | 50.5 | 0.04* |
Sex (Male) (%) | 2,952 (69.5Â %) | 40,893 (66.6Â %) | <0.0001* | 834 (67.6Â %) | 4,559 (66.8Â %) | 0.58 |
BMI | ||||||
 Underweight (%) (BMI < 18.5 kg/m2) | 104 (2.5 %) | 1,498 (2.4 %) | 0.97 | 51 (4.1 %) | 173 (2.5 %) | 0.002* |
 Overweight (%) (≥25 kg/m2) | 1,418 (33.4 %) | 21,605 (35.2 %) | 0.018* | 401 (32.5 %) | 2,454 (36.0 %) | 0.02* |
 Obese (%) (BMI ≥ 30 kg/m2) | 1,549 (36.5 %) | 20,003 (32.6 %) | <0.0001* | 392 (31.8 %) | 2,184 (32 %) | 0.90 |
Clinical Factors | ||||||
 TIPSS (%) at the time of LTX | 502 (11.8 %) | 5,156 (8.4 %) | <0.0001* | 93 (7.5 %) | 510 (7.5 %) | 0.06 |
 Portal Hypertensive Bleeding (%) at time of LTX | 73 (8.8 %) | 636 (4.4 %) | <0.0001* | 9 (2.8 %) | 129 (6.7 %) | 0.02* |
 Portal Vein Thrombosis (%) at the time of LTX | -- | -- | -- | 136 (11.0 %) | 373 (5.4 %) | <0.0001* |
 Diabetes mellitus (%) | 925 (23.9 %) | 8,586 (15.5 %) | <0.0001* | 140 (12.7 %) | 700 (11.7 %) | 0.39 |
 Autoimmune Cirrhosis (%) | 135 (3.2 %) | 1,607 (2.6 %) | 0.03* | 42 (3.8 %) | 165 (2.7 %) | 0.05* |
 Primary Sclerosing Cholangitis (%) | -- | -- | -- | 97 (7.9 %) | 288 (4.2 %) | <0.0001* |
 Primary Biliary Cirrhosis (%) | -- | -- | -- | 48 (4.3 %) | 158 (2.6 %) | 0.002* |
 Hepatocellular carcinoma (%) | 146 (3.8 %) | 1,809 (3.2 %) | 0.05* | 23 (2.0 %) | 258 (2.5 %) | 0.33 |